Navigation Links
Nonin Medical Launches Onyx® Vantage 9590 Professional Finger Pulse Oximeter at ERS Annual Congress
Date:9/26/2011

MINNEAPOLIS, Sept. 26, 2011 /PRNewswire/ -- Nonin Medical, Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, today announced the launch of the Onyx® Vantage 9590 professional finger pulse oximeter at the European Respiratory Society (ERS) 2011 Annual Congress in The Netherlands. The Onyx® Vantage accurately captures SpO2 and pulse rate measurements even in the presence of low perfusion. The new device features 6,000 spot checks, making it the most versatile and reliable finger pulse oximeter for clinicians.  

(Photo: http://photos.prnewswire.com/prnh/20110926/CG75054)

"Every day, Nonin strives to bring the best monitoring solutions to clinicians who manage a broad range of patients. We are committed to developing innovative solutions that provide accurate and reliable SpO2 and pulse rate measurements that clinicians can act on to improve patient outcomes," said Kevin McGowan, vice president of global sales at Nonin Medical. "Onyx Vantage realizes this goal by not only offering clinicians proven accuracy in the widest range of patients, but also in patients with low perfusion and dark skin pigmentation. No other finger pulse oximeter on the market performs better."

The new Onyx® Vantage finger pulse oximeter is engineered with Nonin Medical's clinically proven PureSAT™ pulse oximetry technology – the same accurate technology used in its full line of oximeters. Peer-reviewed articles about Nonin's proven accuracy can be found online at www.onyxvantage.com.

About Nonin Medical, Inc.

Nonin Medical, Inc. is the inventor of fingertip and wireless fingertip pulse oximetry. Headquartered in Minneapolis, Minn., USA, with an additional service center in Hudiksvall, Sweden, Nonin Medical designs and manufactures noninvasive pulse oximeters, regional oximeters, capnographs, sensors, software and accessories globally. The company distributes its products to health professionals and consumers in more than 125 countries and has more than 100 OEM partners worldwide.

As a founding member of the Continua Alliance and a Bluetooth SIG CES Award winner, Nonin Medical is dedicated to developing low power, interoperable technology to reduce healthcare costs and improve quality of life. Since launching the world's first Continua™-certified product in 2009, the company continues to lead the industry in simplifying the exchange of healthcare information while driving global connectivity standards and adding interoperable solutions across its product line. For more information, visit www.nonin.com.


'/>"/>
SOURCE Nonin Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
2. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
3. Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market
4. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
5. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
6. Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification
7. New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
8. Nonin Medical Recognized for Influential Contributions in Medical Technology
9. Noninvasive Breath Test Predicts Survival in Patients with Viral Hepatitis
10. Nonin Medical Announces Expanded Distribution Partnership With CareFusion
11. Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 - bioLytical lanza el ... directrices de la OMS     Continue Reading ... ... , , ... infecciosas, ha anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV ...
(Date:12/2/2016)... , December 2, 2016 ... global cardiac pacemaker market in its upcoming report titled, "Global Market Study ... a Declining CAGR of -1.4% between 2016 and 2024". The ... Mn in 2015 and this is likely to decline ... revenue, the global cardiac pacemaker market is anticipated to ...
(Date:12/2/2016)... , Dec. 2, 2016  LifeVac, the revolutionary device ... in the Emergency Response Training and Support Services (ERTSS) ... to have LifeVac become part of the ERTSS mission ... and CEO of LifeVac. "Having an established network of ... effectively will help leverage our efforts to spread LifeVac,s ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of travel therapy ... MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason ... extensive financial and operational leadership experience to Advanced Inc. He began his career in ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
(Date:12/2/2016)... Delaware (PRWEB) , ... December 02, 2016 , ... ... released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps ... sample entry through labeling, storing, shipping and disposal. The new version is a ...
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The ... how this current generation fits into Bible Prophecy. Yisrayl says this generation, known as ... to this conclusion, showing how the details line up exactly with Bible Prophecy – ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... Technologist/Clinical Laboratory Scientist & Author of Type 2 Diabetes: The Owner’s Manual, ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ...
Breaking Medicine News(10 mins):